1st paragraph of story should go here

Disgraced financier Bernard Madoff's longtime auditor has entered a guilty plea in a federal court in Manhattan.

The director of the FDA's division of antiviral products is urging caution in the use of a new flu drug that just won special permission to fight H1N1.

A large study being published in a major medical journal says certain kidney disease patients who get the drug Aranesp to treat anemia-related fatigue may be at greater risk of having a stroke.

New York Attorney General Andrew Cuomo and 14 other states are filing a lawsuit against Amgen, alleging that the biotech company was offering kickbacks to medical providers to increase the sale of its anemia drug Aranesp.

Stryker Biotech and top management have been indicted on charges they engaged in a fraudulent marketing scheme for certain medical devices, the U.S. Justice Department said on Wednesday.

The linking of Advanced Micro Device's former top executive to the largest U.S. insider trading scheme in decades may raise questions about its business practices.

Galleon Group founder Raja Rajaratnam, accused in the biggest ever U.S. criminal prosecution of insider trading at a hedge fund, retained high- powered Washington lawyer John Dowd to represent him.

Federal prosecutors in the Galleon Group case have sent a subpoena to a former employee of Steven A. Cohen's SAC Capital Advisors, a sign that the scope of the problem into the largest hedge fund insider trading case in history is expanding, the Wall Street Journal reported, citing people familiar with the matter.

The Smart Choices nutrition labeling program, created voluntarily by nine large U.S. manufacturers, is halting after federal regulators said such systems could mislead consumers, officials with the labeling group said Friday.

A new study shows that a diabetes treatment awaiting FDA approval may also work as a weightloss drug.

The Food and Drug Administration approved the new swine flu vaccine Tuesday, a long-anticipated step as the government works to get vaccinations under way next month.

A recent court ruling that forced two ratings companies to defend fraud claims is a "game-changer" for the industry, said David Einhorn, head of Greenlight Capital.

A global crackdown on bank secrecy and offshore tax havens is gaining steam due to  the worldwide financial crisis, the head of the OECD told CNBC.

The industry self-regulatory organization that was supposed to police the brokers at the Stanford Financial Group acknowledges it received a tip from an employee in 2003 that the company was running a Ponzi scheme, but did not follow up on it because of the agency's own policy.